Research Partnerships

Molecure is committed to partnering with the world’s leading research institutions in the fight against serious illness. In these partnerships, we seek to leverage our deep scientific expertise in oncology, fibrotic and inflammatory diseases and outstanding capabilities in the discovery and development of small-molecule drugs together with our partners expertise in identifying novel targets and lead compounds to expand and advance our novel small molecule pipeline modulating challenging protein targets with the potential to develop curative treatments.

A key element of Molecure’s strategy is based on partnering with companies and organizations whose strengths complement its own.